Related content

Fatal intoxication cases: cytochrome P ₄₅₀ 2D6 and 2C19 genotype distributions

By Zackrisson A.   Holmgren P.   Gladh A.   Ahlner J.   Lindblom B.  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 547-552

Springer Publishing Company

Access to resources Recommend Favorite

Effect of the novel anxiolytic drug deramciclane on cytochrome P ₄₅₀ 2D6 activity as measured by desipramine pharmacokinetics

By Laine Kari   Bruyn Steven   Björklund Harry   Rouru Juha   Hänninen Jutta   Scheinin Harry   Anttila Markku  

European Journal of Clinical Pharmacology, Vol. 59, Iss. 12, 2004-02 ,pp. : 893-898

Springer Publishing Company

Access to resources Recommend Favorite

Reduced cytochrome P450 (CYP) 2D6 activity may contribute to an interaction between tramadol and warfarin

By  

Reactions Weekly, Vol. 1, Iss. 1017, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Genetic polymorphism of cytochrome P₄₅₀ 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions

By Lee Ai-Young   Kim Min-Jung   Chey Won-Young   Choi Jun   Kim Byung-Gun  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 155-159

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P₄₅₀ 2C9 phenotyping using low-dose tolbutamide

By Jetter Alexander   Kinzig-Schippers Martina   Skott Andreas   Lazar Andreas   Tomalik-Scharte Dorota   Kirchheiner Julia   Walchner-Bonjean Monika   Hering Ursula   Jakob Verena   Rodamer Michael   Jabrane Wafaâ   Kasel Dirk   Brockmöller Jürgen   Fuhr Uwe   Sörgel Fritz  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite